Scientific Computing World is hosting a virtual roundtable (limited to 6-8 participants) in February (date tbc) for research leaders, scientists and R&D experts in drug discovery, particularly those working with new modalities, such as RNA therapeutics, gene therapies, ADCs (Antibody Drug Conjugates) and protein degraders.
With these new multiple modalities, existing software solutions may not be fit for purpose, so the discussion will explore how research teams are adapting to this changing landscape and what challenges and considerations they face.
This roundtable provides research leaders with the opportunity to learn from each other’s experience in managing these major changes in drug discovery – and, in particular, how they affect interaction with digital platforms on which research data is recorded and shared.
Who should attend?
- Project, programme and research group leaders
- Principal Scientists within Medicinal Chemistry, Discovery Biology
- R&D IT experts/consultants
- Those working in pharmaceutical and biotech R&D
Questions we plan to address include:
- What challenges have you faced when working with these new modalities from a software platform perspective – and how have you overcome them?
- With multimodal projects, such as ADCs or islet cell therapies, how do you foster collaboration between biology, chemistry, data science and external teams. How do software platforms help or hinder that collaboration?
- Different types of modalities generate different types of datasets – how do you approach organising and analysing these data to make decisions more efficiently? What standard do you follow to represent your new modalities so as to register and compare them easily?
- Cultural challenges – how have you embedded change management when it comes to adopting a new software platform or data management policies?
- How are you using artificial intelligence (AI) and machine learning (ML) in accelerating the development of these complex modalities?
- Are there any ways in which software platforms can better assist your research, e.g. new features, levels of support, etc?
To apply for a place on the roundtable, please email Warren Clark, CEO of Europa Science and moderator of the event. There is no charge to attend.
Read the summary of the last roundtable we held here, which looked at data issues in pharmaceutical manufacturing.
The roundtable is being held in partnership with Revvity Signals.
